+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial



The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial



International Wound Journal 12(2): 137-142



Foot ulcers are major sources of morbidity in individuals with diabetes mellitus. As royal jelly (RJ, a worker honey bee product) contains enzymatic, antibacterial and vasodilative properties, it can potentially help in healing of diabetic foot ulcers (DFUs). This study aimed to evaluate the efficacy of topical RJ on healing of DFUs. Diabetic patients with foot ulcers who were referred to us at Khorshid Hospital, Isfahan, Iran, were managed by offloading, infection control, vascular improvement and debridement (if required). Then, all ulcers were randomly selected to receive either 5% sterile topical RJ or placebo on their total surface area. Patients were followed for 3 months or until complete healing. Twenty-five patients (6 females and 19 males) and a total of 64 ulcers were included and randomly allocated to case or control group (32 per group). Four ulcers were excluded and 60 ulcers included in the final analysis. Healing parameters including depth, length and width reduction rate, duration of complete healing and incidence of complete healing did not show any significant difference (P = 0·69, 0·95, 0·7, 0·74 and 0·6, respectively) between groups. We did not observe any side effect of topical RJ application. This study could not confirm any significant superiority of 5% topical RJ over placebo for the treatment of DFUs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036841640

Download citation: RISBibTeXText

PMID: 23566071

DOI: 10.1111/iwj.12063


Related references

The efficacy of topical Royal Jelly on diabetic foot ulcers healing: A case series. Journal of Research in Medical Sciences 16(7): 904-909, 2012

Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15(11): 1598-1604, 1992

Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. Diabetes Research and Clinical Practice 142: 335-344, 2018

Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON. Trials 8: 26, 2007

A Randomized, Double-Blind, Placebo-Controlled Trial on Clinical Efficacy of Topical Agents in Reducing Pain and Frequency of Recurrent Aphthous Ulcers. Open Dentistry Journal 12: 700-713, 2018

Visible light-induced healing of diabetic or venous foot ulcers: a placebo-controlled double-blind study. Photomedicine and Laser Surgery 29(6): 399-404, 2011

The efficacy of topical phenytoin in the healing of diabetic foot ulcers: a randomized double-blinded trial. International Journal of Diabetes in Developing Countries 37(1): 46-49, 2017

NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial. Wound Repair and Regeneration 20(4): 482-490, 2012

Topical use of granulocyte-macrophage colony-stimulating factor in patients with diabetic foot ulcers, a randomized, double-blind, placebo-controlled study. Journal of Investigative Medicine 48(1): 168A, 2000

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial. Journal of Diabetes Research 2017: 3159798, 2018

Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study. Journal of Diabetes Investigation 5(4): 392-399, 2014

Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care 26(9): 2575-2580, 2003

Topical morphine gel in the treatment of painful leg ulcers, a double-blind, placebo-controlled clinical trial: a pilot study. International Wound Journal 9(4): 419-427, 2012

Topical 5 methylthioadenosine mta in the treatment of chronic venous ulcers results of a double blind placebo p controlled clinical trial. European Journal of Clinical Investigation 20(2 PART 2): A17, 1990

Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 18(1): 64-69, 1995